Viewing Study NCT00301834


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2025-12-26 @ 1:03 AM
Study NCT ID: NCT00301834
Status: COMPLETED
Last Update Posted: 2017-09-28
First Post: 2006-03-09
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
Sponsor: University of California, San Francisco
Organization: